Bright Minds Biosciences Inc. (DRUG)
NASDAQ·Healthcare·Biotechnology
$55.41
+2.58%
Mkt Cap $544.50M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (8 analysts)
$171.67
Range $145.00 – $220.00
Implied Upside
+209.8%
Consensus $171.67 vs current $55.41